Your browser doesn't support javascript.
loading
Health-related quality of life with idecabtagene vicleucel in relapsed and refractory multiple myeloma.
Delforge, Michel; Shah, Nina; Miguel, Jesús San F; Braverman, Julia; Dhanda, Devender S; Shi, Ling; Guo, Shien; Yu, Peiwen; Liao, Weiqin; Campbell, Timothy B; Munshi, Nikhil C.
Afiliação
  • Delforge M; University Hospital Leuven, Leuven, Belgium.
  • Shah N; University of California San Francisco, San Francisco, CA.
  • Miguel JSF; Clínica Universidad de Navarra, Navarra, Spain.
  • Braverman J; Bristol Myers Squibb, Princeton, NJ.
  • Dhanda DS; Bristol Myers Squibb, Princeton, NJ.
  • Shi L; Evidera, Waltham, MA; and.
  • Guo S; Evidera, Waltham, MA; and.
  • Yu P; Evidera, Waltham, MA; and.
  • Liao W; Evidera, Waltham, MA; and.
  • Campbell TB; Bristol Myers Squibb, Princeton, NJ.
  • Munshi NC; The LeBow Institute for Myeloma Therapeutics and Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.
Blood Adv ; 6(4): 1309-1318, 2022 02 22.
Article em En | MEDLINE | ID: mdl-34933328
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Receptores de Antígenos Quiméricos / Mieloma Múltiplo Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Receptores de Antígenos Quiméricos / Mieloma Múltiplo Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article